Location History:
- Farmingdale, NY (US) (2000)
- Farmington, NY (US) (2021)
Company Filing History:
1 out of 1 
1 out of 832,966 Years Active: 2000-2021
Title: Aftab S Karim: Innovator in Antibody Research
Introduction
Aftab S Karim is a notable inventor based in Farmington, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies and methods for treating challenging medical conditions. With a total of 2 patents, his work is paving the way for advancements in targeted therapies.
Latest Patents
Karim's latest patents include groundbreaking research on antibodies and antibody fragments against the CD155 receptor. This humanized antibody to the poliovirus receptor can be utilized to target nucleic acids, proteins, and chemicals specifically to brain cancer cells. This approach offers a promising treatment for tumors that are difficult to address due to the challenges of delivering therapies through the blood-brain barrier. Another significant patent involves the inhibition of interleukin-5 expression. This method employs an antisense oligonucleotide containing at least one non-natural internucleoside linkage to effectively inhibit interleukin-5 expression.
Career Highlights
Throughout his career, Aftab S Karim has worked with various organizations, including Tasrif Pharmaceutical, LLC. His innovative research has contributed to the development of therapies that address critical health issues.
Collaborations
Karim has collaborated with notable professionals in his field, including Robert G Holgate and Arron Hearn. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Aftab S Karim is a distinguished inventor whose work in antibody research is making significant strides in medical science. His patents reflect a commitment to developing effective treatments for complex health challenges.